Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy
Link
http://link.springer.com/article/10.1186/1472-6963-14-73/fulltext.html
Reference37 articles.
1. Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002, 24: 46-54. 10.1023/A:1015570104121.
2. Dormann H, Mulh-Selbach U, Krebs S, et al: Incidence and costs of adverse drug reactions during hospitalization: Computerized monitoring versus stimulated spontaneous reporting. Drug Saf. 2000, 22: 161-168. 10.2165/00002018-200022020-00007.
3. Bordet R, Gautier S, le Louet H, et al: Analysis of the direct cost of adverse drug reactions in hospitalized patients. Eurff Clin Pharmacol. 2001, 56: 935-941. 10.1007/s002280000260.
4. White TJ, Arakelian A, Rho J: Counting the costs of drug-related adverse events. Pharmacoeconomics. 1999, 15: 445-448. 10.2165/00019053-199915050-00003.
5. Johnson JA, Bootman JL: Drug-related morbidity and mortality. A cost-of-illness model. Arch Inter Med. 1995, 155: 1949-1956. 10.1001/archinte.1995.00430180043006.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?;Cost Effectiveness and Resource Allocation;2024-02-06
2. Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China;European Journal of Clinical Pharmacology;2023-12-27
3. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates;Journal of Pharmaceutical Policy and Practice;2023-07-18
4. Research on prescribing cascades: a scoping review;Frontiers in Pharmacology;2023-07-03
5. All-round approaches to increase adverse drug reaction reports: a scoping review;Drugs & Therapy Perspectives;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3